Acousia Completes Patient Enrollment for Cisplatin Ototoxicity Prevention Study
The Phase 2 PROHEAR trial is evaluating ACOU085 (Bimokalner) for its efficacy in protecting hearing during chemotherapy.
Tag: original
All
Latest
All
Latest
AI Enables “Predict-to-Prescribe” Approach for Children Receiving Cochlear Implants
A deep transfer learning AI model predicted spoken language outcomes in children one to three years after cochlear implantation with 92% accuracy.
All
Latest
APSO Publishes One Tinnitus Standard, Opens Another for Public Review
APSO has released its finalized tinnitus evaluation standard while opening a complementary tinnitus treatment and management standard for public review to advance evidence-based audiology practice.
FDA Approves Med-El Cochlear Implant for Children 7 Months and Older
The FDA has approved an expanded indication for Med-El cochlear implants for children seven months and older with bilateral sensorineural hearing loss.
Read More
Hearing Loss Test Checks Eyes Instead of Ears
A new hearing test measures how a patient’s pupils involuntarily change size in response to sound.
Read More
GN Celebrates Grand Opening of New North American HQ
GN has officially opened its new 218,000-square-foot North American headquarters in Shakopee, Minnesota, establishing a modern manufacturing and distribution hub for all GN brands.
Read More
Oticon Focus on People Awards Recognizes 2025 Winners
The 2025 Oticon Focus on People Awards honored three individuals with hearing loss for their advocacy, leadership, and innovation.
Read More
Study: One in Eight Teens Shows Signs of Hearing Damage by 18
A major longitudinal study of more than 3,300 teens finds that by age 18, one in eight adolescents shows signs of probable noise-induced hearing damage and over 6% have sensorineural hearing loss.
Read More
Study Reveals the ‘Goldilocks’ Echo That Boosts Speech Understanding
Researchers at Macquarie University have discovered that the human brain rapidly adapts to the acoustic characteristics of spaces, with speech understanding optimized in environments with a moderate amount of reverberation.
Read More
Pickleball Pro Back in the Game with Hearing Aids
Pickleball pro Miguel Enciso reclaims full social connection and on-court comfort with hearing aids customized to support his life.
Read More
Starkey Named to Fast Company’s 2025 Next Big Things in Tech List
Starkey has been recognized on Fast Company’s Next Big Things in Tech list for its AI-driven hearing innovations.
Read More
Research Reveals New Clues to Middle-Ear Hearing Damage with Digital Reconstruction
A new digital reconstruction study shows that middle-ear hearing loss becomes severe when fluid occupies about half of the ear cavity, offering a non-invasive marker for diagnosing and staging otitis media with effusion.
Read More
Suno Software to Accelerate AI Innovation with New Funding
Suno Software has secured new funding to rapidly expand its AI-driven practice management platform, aiming to streamline clinic operations and enhance patient care in hearing health.
Read More
Case Study: Vestibular Migraine or POTS?
A 14-year-old girl’s vestibular evaluation reveals overlapping signs of vestibular migraine and postural orthostatic tachycardia syndrome (POTS), complicating the diagnosis.
Read More
Widex Expands Allure Portfolio in the United States
Widex has expanded its Allure portfolio in the U.S. with new BTE and ITE models—including its first rechargeable ITE—and a portable RIC charger.
Read More
Neurotone AI Launches Tinnitus Pro
Neurotone AI has launched Tinnitus Pro, a personalized digital tinnitus therapy platform that blends sound therapy, CBT-based tools, and clinician-connected monitoring.
Read More
ReSound 2025 Gift of Hearing Campaign Kicks Off
ReSound’s 2025 Gift of Hearing campaign invites hearing care professionals across North America to partner with them to donate hearing aids and services to people with financial hardship.
Read More
NAL and MedRx Announce Integration of NAL-NL3 Fitting Formula in Latest MedRx Software
National Acoustic Laboratories (NAL) and MedRx have worked together to bring the next-generation NAL-NL3 fitting formula to MedRx’s verification and testing systems.
Read More